Aggressive B-cell Lymphoma with MYC/TP53 Dual Alterations Displays Distinct Clinicopathobiological Features and Response to Novel Targeted AgentsManman Deng, Ken H. Young, Lan V. Pham et al.|Molecular Cancer Research|2020Cited by 38